Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 11/2021

01-11-2021 | Osteoporosis | Original Article

Bone turnover markers as determinants of bone density and fracture in men with distal forearm fractures: the pathogenesis examined in the Mr F study

Authors: B. Hanusch, M. Prediger, S.P. Tuck, J. Walker, R. McNally, H.K. Datta

Published in: Osteoporosis International | Issue 11/2021

Login to get access

Abstract

Summary

The pathogenesis for low-trauma wrist fractures in men is not fully understood. This study found that these men had evidence of significantly higher bone turnover compared with control subjects. Bone turnover markers were negative predictors of bone mineral density and were a predictor of fracture.

Introduction

Men with distal forearm fractures have reduced bone density, an increased risk of osteoporosis and of further fractures. The aim of this study was to investigate whether or not men with distal forearm fractures had evidence of altered bone turnover activity.

Methods

Fifty eight men with low-trauma distal forearm fracture and 58 age-matched healthy control subjects were recruited. All subjects underwent a DXA scan of the forearm, both hips, and lumbar spine, biochemical investigations, and health questionnaires. Measurements of beta crosslaps (βCTX), procollagen type I N-terminal propeptide (PINP), sclerostin, Dickkopf-1 (Dkk1), and fibroblast growth factor 23 (FGF 23) were made.

Results

Men with fracture had significantly higher PINP than controls at 39.2 ng/ml (SD 19.5) versus 33.4 ng/ml (SD13.1) (p<0.001). They also had significantly higher βCTX at 0.45 ng/ml (SD 0.21) versus 0.37 ng/ml (SD 0.17) (p= 0.037). Fracture subjects had significantly lower aBMD and PINP was a negative predictor of aBMD at the total hip and βCTX a negative predictor of forearm aBMD. Sclerostin was a positive predictor of aBMD at the lumbar spine and hip sites. Sex hormone binding globulin (SHBG) at 37nmol/L (SD 15.0) was lower in fracture cohort compared to 47.9 nmol/L (SD 19.2) (p=0.001) in control. Multiple regression revealed that the best model for prediction of fracture included SHBG, P1NP, and ultra-distal forearm aBMD. The likelihood of distal forearm fracture was decreased by 5.1% for each nmol/L increase in SHBH and by 1.4% for every mg/cm2 increase in ultra-distal forearm aBMD, but increased by 6.1 % for every ng/ml increase in P1NP. Men in the highest quartile of PINP had a significantly greater likelihood of distal forearm fracture than those in the lowest quartile.

Conclusion

The fracture group had significantly higher PINP and βCTX compared with the control group, and these markers were negative predictors of aBMD at the total hip and forearm sites, respectively. Sclerostin was a positive predictor of the variance of spinal and hip aBMD. Likelihood of forearm fracture was best predicted by a combination of SHBG, PINP, and ultra-distal forearm aBMD. Findings of such cross-sectional data should be treated with caution, as longitudinal studies would be required to confirm or refute them.
Appendix
Available only for authorised users
Literature
1.
Tuck SP, Francis RM, Hanusch B (2012) Osteoporosis in men. Oxford Rheumatology Library: Osteoporosis- edited by Gavin Clunie and Richard Keen. Oxford University Press
2.
Tuck SP, Raj N, Summers GD (2002) Is distal forearm fracture in men due to osteoporosis? Osteoporos Int 13(8):630–636CrossRef
3.
Hanusch BC, Tuck SP, McNally RJQ et al (2017) Does regional loss of bone mineral density explain low trauma distal forearm fractures in men (the MrF study)? Osteoporos Int 28(10):2877–2886CrossRef
4.
Vasikaran S, Eastell R, Bruyere O et al (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international standards. Osteoporos Int 22(2):391–420CrossRef
5.
Atkins GJ, Findlay DM (2012) Osteocyte regulation of bone mineral: a little give and take. Osteoporos Int 23(8):2067–2079CrossRef
6.
Datta HK, Ng WF, Walker JA, Tuck SP, Varanassi SS (2008) Cell biology of bone. J Clin Pathol 61(5):577–587CrossRef
7.
Hay E, Bouaziz W, Funck-Brentano T, Cohen-Solal M (2016) Sclerostin and bone aging: a mini review. Gerentology 62:618–623CrossRef
8.
Abdallah E, Mosbath O, Khalifa G, Metwaly A, El-Bendary O (2016) Assessment of the relationship between serum soluble Klotho and carotid intima-media thickness and left ventricular dysfunction in hemodialysis patients. Kidney Res Clin Pract 35(1):42–49CrossRef
9.
Heiland GR, Appel H, Poddabnyy D et al (2012) High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis. Ann Rheum Dis 71(4):572–574CrossRef
10.
Stoch SA, Zajic S, Stone JA, Miller DL, van Bortel L, Lasseter KC, Pramanik B, Cilissen C, Liu Q, Liu L, Scott BB, Panebianco D, Ding Y, Gottesdiener K, Wagner JA (2013) Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics--results from single oral dose studies in healthy volunteers. Br J Clin Pharmacol 75(5):1240–1254CrossRef
11.
Lapauw B, Vandewalle S, Taes Y eta l. (2013) Serum sclerostin levels in men with idiopathic osteoporosis. Eur J Endocrinol 168:615–620CrossRef
12.
Pernu P, Gaddnas F, Risteli J et al (2015) Type 1 and 3 collagen production by bone marrow mesenchymal stromal cells is suppressed in vitro after exposure to sepsis patient serum. Intens Care Med Exp 3:A639CrossRef
13.
Szulc P, Munoz F, Claustrat B, Gannero P, Marcland F, Duboeaf F, Delmas PD (2001) Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. J Clin Endocrinol Metab 86(1):192–199PubMed
14.
Evans SF, Davie MW (2002) Low body size and elevated SHBG distinguish men with idiopathic vertebral fracture. Calcif Tissue Int 70:9–15CrossRef
15.
Pietschmann P, Kudlacek S, Grisar J, Spitzauer S, Woloszczuk W, Willvonseder R, Peterlik M (2001) Bone turnover markers and sex hormones in men with idiopathic osteoporosis. Euro J Clin Inv 31(5):444–451CrossRef
16.
Tuck SP, Scane AC, Francis RM et al (2008) A case control study of sex steroids and bone turnover in men with symptomatic vertebral fractures. Bone 43(6):999–1005CrossRef
17.
Montoya MJ, Giner M, Miranda C, Vázquez MA, Caeiro JR, Guede D, Pérez-Cano R (2014) Microstructural trabecular bone from patients with osteoporotic hip fracture or osteoarthritis: its relationship with bone mineral density and bone remodelling markers. Maturitas 79(3):299–305CrossRef
18.
Chubb SA, Byrnes E, Manning C et al (2015) Reference intervals for bone turnover markers and their association with incident hip fractures in older men: the health in men study. J Clin Endocrinol Metab 100(1):90–99CrossRef
19.
Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T (2011) Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: a 10 years follow up of the Taiji cohort. Mod Rheumatol 21(6):608–620CrossRef
20.
Ardawi MS, Rouzi AA, Al-Sibiani SA et al (2012) High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study. J Bone Miner Res 27(12):2592–2602CrossRef
21.
Polyzos SA, Anatasilakis AD, Bratengeier C et al (2012) Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide. Osteoporos Int 23(3):1171–1176CrossRef
22.
Garnero P, Sornay-Rendu E, Munoz F, Borel O, Chapurlat RD (2013) Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int 24(2):489–494CrossRef
23.
Reppe S, Noer A, Grimholt RM, Halldórsson BV, Medina-Gomez C, Gautvik VT, Olstad OK, Berg JP, Datta H, Estrada K, Hofman A, Uitterlinden AG, Rivadeneira F, Lyle R, Collas P, Gautvik KM (2015) Methylation of bone sclerostin, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women. J Bone Miner Res 30(2):249–256CrossRef
24.
Gaudio A, Pennizi P, Bratengeier C et al (2010) Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab 95(5):2248–2253CrossRef
25.
Kalogeroulos M, Varanasi SS, Olstad OK et al (2010) Zic1 transcription factor in bone: neural developmental protein regulates mechanotransduction in osteocytes. FASEB J 24(8):2893–2903CrossRef
26.
Mirza MA, Karlsson MK, Mellstrom D et al (2011) Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men. J Bone Miner Res 26:4857–4864CrossRef
27.
Lane NE, Parini N, Corr M et al (2013) Association of serum fibroblast growth factor 23 (FGF23) and incident fractures in older men: the Osteoporotic fractures in men (Mr Os) study. J Bone Miner Res 28(11):2325–2332CrossRef
28.
Lourneau C, Soudan B, d’Herbomez M eta l. (2004) Sex hormone binding globulin, estradiol and bone turnover markers in male osteoporosis. Bone 34(6):933–939CrossRef
29.
Legrand E, Hedde C, Gallois Y et al (2001) Osteoporosis in men: a potential role for the sex hormone binding globulin. Bone 29(1):90–95CrossRef
30.
Risto O, Hammer E, Hammer K et al (2012) Elderly men with a history of distal radius fracture have significantly lower calcaneal bone density and free androgen index than age-matched controls. Aging Male 1591:59–62CrossRef
31.
Rucker D, Ezzat S, Diamandi A, Khosravi J, Hanley DA (2004) IGF-1 and testosterone levels are predictors of bone mineral density in healthy community dwelling men. Clin Endocrinol 60(45):491–499CrossRef
32.
Slemenda CW, Longcope C, Zhou L, Hui SL, Peacock M, Johnston CC (1997) Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens. J Clin Invest 100(7):1755–1759CrossRef
33.
Martinez Diaz-Guerra G, Hawkins F, Rapado A et al (2001) Hormonal and anthropometric predictors of bone mass in healthy elderly men: major effect of sex hormone binding globulin, parathyroid hormone and body weight. Osteoporos Int 12(3):178–184CrossRef
34.
Center JR, Nguyen TV, Sambrood PN, Eisman JA (2000) Hormonal and biochemical parameters and osteoporotic fractures in elderly men. J Bone Miner Res 15(7):1405–1411CrossRef
35.
Bjornerem A, Emaus N, Berntsen GK et al (2007) circulating sex steroids, sex hormone binding globulin and longitudinal changes in forearm bone density in postmenopausal women and men: the Tromso study. Calcif Tissue Int 81(2):65–72CrossRef
36.
Cawthorn PM, Schousboe JT, Harrison SL et al (2016) Sex hormones, sex hormone binding globulin and vertebral fractures in older men. Bone 84:271–278CrossRef
37.
Vandenput L, Mellstrom D, Kindmark A et al (2016) High serum SHBG predicts incident vertebral fractures in elderly men. J Bone Miner Res 31(3):683–689CrossRef
38.
El Maghraoui A, Ouzzif Z, Mounach A et al (2011) The relationship between sex steroids, bone turnover and vertebral fracture prevalence in asymptomatic men. Bone 49(4):853–857CrossRef
39.
Mellstrom D, Vandenput L, Mallmin H et al (2008) Older men with low serum estradiol and high SHBG have an increased risk of fractures. J Bone Miner Res 23(10):1552–1560CrossRef
40.
41.
Ingle BM, Hay SM, Bottjer HM, Eastell R (1999) Changes in bone mass and bone turnover following distal forearm fracture. Osteoporos Int 10:399–407CrossRef
42.
Hojsager FD, Rand MS, Pederson SB, Nissen N, Jorgensen NR (2019) Fracture-induced changes in biomarkers CTX, PINP, OC and BAP- a systematic review. Osteoporos Int 30:2381–2389CrossRef
Metadata
Title
Bone turnover markers as determinants of bone density and fracture in men with distal forearm fractures: the pathogenesis examined in the Mr F study
Authors
B. Hanusch
M. Prediger
S.P. Tuck
J. Walker
R. McNally
H.K. Datta
Publication date
01-11-2021
Publisher
Springer London
Published in
Osteoporosis International / Issue 11/2021
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-021-06001-6

Other articles of this Issue 11/2021

Osteoporosis International 11/2021 Go to the issue

Original Article

Analysis of the effects of a delay of surgery in patients with hip fractures: outcome and causes

Original Article

A 1:1 matched case-control study on dietary protein intakes and hip fracture risk in Chinese elderly men and women

Case Report

Denosumab for the treatment of primary pediatric osteoporosis

Original Article

Predictive ability of novel volumetric and geometric indices derived from dual-energy X-ray absorptiometric images of the proximal femur for hip fracture compared with conventional areal bone mineral density: the Japanese Population-based Osteoporosis (JPOS) Cohort Study

Original Article

Osteoporosis treatment with risedronate: a population pharmacokinetic model for the description of its absorption and low plasma levels

Original Article

Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study